# Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)

Study · id `cardio:ct-nct03906799` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03906799](<https://clinicaltrials.gov/study/NCT03906799>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03906799

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

## Technical summary

Registry record NCT03906799. Randomized; triple masking; primary purpose treatment. Start 2019-03-19 (actual); primary completion 2019-11-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 136 participants (enrolled count; ClinicalTrials.gov record NCT03906799, source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)
- Started: 2019-03-19 (actual) (ClinicalTrials.gov record NCT03906799, source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)
- Primary completion: 2019-11-20 (actual) (ClinicalTrials.gov record NCT03906799, source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)
- Completion: 2020-03-20 (actual) (ClinicalTrials.gov record NCT03906799, source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)
- Countries: Bulgaria; Czechia; Hungary; Ukraine (ClinicalTrials.gov record NCT03906799, source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03906799-2021-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
- Acronym: PROMISE-AF
- Condition: Atrial Fibrillation
- Intervention (Drug): OMT-28
- Intervention (Drug): Placebo
- Lead sponsor: Omeicos Therapeutics GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: cec0bc0cc936137049d3e0f53d1d8ba82261d97d87294c922392a8ede0f3946a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
